Grandfield & Dodd’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22.8M | Sell |
163,600
-8,425
| -5% | -$1.18M | 1.29% | 29 |
|
|
2025
Q4 | $21.1M | Sell |
172,025
-28,306
| -14% | -$3.44M | 1.2% | 32 |
|
|
2025
Q3 | $22.2M | Sell |
200,331
-20,655
| -9% | -$2.35M | 1.26% | 28 |
|
|
2025
Q2 | $24.5M | Sell |
220,986
-60,746
| -22% | -$6.46M | 1.43% | 24 |
|
|
2025
Q1 | $31.6M | Sell |
281,732
-2,030
| -0.7% | -$209K | 1.96% | 17 |
|
|
2024
Q4 | $26.2M | Sell |
283,762
-1,147
| -0.4% | -$103K | 1.62% | 23 |
|
|
2024
Q3 | $23.9M | Buy |
284,909
+1,945
| +0.7% | +$148K | 1.42% | 26 |
|
|
2024
Q2 | $19.4M | Buy |
282,964
+3,230
| +1% | +$216K | 1.23% | 30 |
|
|
2024
Q1 | $20.5M | Sell |
279,734
-1,246
| -0.4% | -$95.8K | 1.29% | 30 |
|
|
2023
Q4 | $22.8M | Sell |
280,980
-97
| -0% | -$7.55K | 1.57% | 25 |
|
|
2023
Q3 | $21.1M | Buy |
281,077
+5,566
| +2% | +$428K | 1.55% | 24 |
|
|
2023
Q2 | $21.2M | Sell |
275,511
-2,826
| -1% | -$225K | 1.48% | 24 |
|
|
2023
Q1 | $23.1M | Buy |
278,337
+2,121
| +0.8% | +$176K | 1.61% | 24 |
|
|
2022
Q4 | $23.7M | Buy |
276,216
+3,968
| +1% | +$314K | 1.74% | 23 |
|
|
2022
Q3 | $16.8M | Buy |
272,248
+8,485
| +3% | +$535K | 1.37% | 34 |
|
|
2022
Q2 | $16.3M | Buy |
263,763
+11,921
| +5% | +$738K | 1.28% | 36 |
|
|
2022
Q1 | $15M | Buy |
251,842
+8,546
| +4% | +$546K | 1.02% | 42 |
|
|
2021
Q4 | $17.7M | Buy |
243,296
+7,042
| +3% | +$485K | 1.14% | 36 |
|
|
2021
Q3 | $16.5M | Buy |
236,254
+13,290
| +6% | +$934K | 1.15% | 36 |
|
|
2021
Q2 | $15.3M | Buy |
222,964
+20,344
| +10% | +$1.36M | 1.06% | 39 |
|
|
2021
Q1 | $13.1M | Buy |
202,620
+16,640
| +9% | +$1.07M | 0.98% | 41 |
|
|
2020
Q4 | $10.8M | Buy |
185,980
+3,370
| +2% | +$203K | 0.85% | 42 |
|
|
2020
Q3 | $11.5M | Buy |
182,610
+3,973
| +2% | +$276K | 1.04% | 38 |
|
|
2020
Q2 | $13.7M | Sell |
178,637
-1,008
| -0.6% | -$77.3K | 1.33% | 31 |
|
|
2020
Q1 | $13.4M | Buy |
179,645
+5,581
| +3% | +$386K | 1.58% | 22 |
|
|
2019
Q4 | $11.3M | Buy |
174,064
+4,475
| +3% | +$291K | 1.03% | 40 |
|
|
2019
Q3 | $10.7M | Buy |
169,589
+3,875
| +2% | +$253K | 1.06% | 40 |
|
|
2019
Q2 | $11.2M | Buy |
165,714
+8,314
| +5% | +$547K | 1.11% | 37 |
|
|
2019
Q1 | $10.2M | Buy |
157,400
+5,970
| +4% | +$397K | 1.07% | 38 |
|
|
2018
Q4 | $9.47M | Sell |
151,430
-605
| -0.4% | -$42.3K | 1.12% | 37 |
|
|
2018
Q3 | $11.7M | Buy |
152,035
+5,430
| +4% | +$410K | 1.21% | 33 |
|
|
2018
Q2 | $10.4M | Buy |
146,605
+7,670
| +6% | +$542K | 1.14% | 38 |
|
|
2018
Q1 | $10.5M | Buy |
138,935
+2,967
| +2% | +$236K | 1.17% | 37 |
|
|
2017
Q4 | $9.74M | Buy |
135,968
+7,898
| +6% | +$600K | 1.04% | 43 |
|
|
2017
Q3 | $10.4M | Buy |
128,070
+26,167
| +26% | +$2M | 1.16% | 39 |
|
|
2017
Q2 | $7.21M | Buy |
101,903
+54,321
| +114% | +$3.61M | 0.85% | 43 |
|
|
2017
Q1 | $3.23M | Buy |
47,582
+30,355
| +176% | +$2.13M | 0.4% | 61 |
|
|
2016
Q4 | $1.23M | Buy |
17,227
+8,584
| +99% | +$638K | 0.16% | 81 |
|
|
2016
Q3 | $684K | Buy |
8,643
+82
| +1% | +$6.66K | 0.09% | 103 |
|
|
2016
Q2 | $714K | Buy |
8,561
+675
| +9% | +$59.9K | 0.1% | 99 |
|
|
2016
Q1 | $724K | Buy |
7,886
+167
| +2% | +$15.1K | 0.1% | 90 |
|
|
2015
Q4 | $781K | Sell |
7,719
-46
| -0.6% | -$4.79K | 0.12% | 90 |
|
|
2015
Q3 | $762K | Buy |
7,765
+1,249
| +19% | +$139K | 0.13% | 89 |
|
|
2015
Q2 | $763K | Sell |
6,516
-2,063
| -24% | -$225K | 0.12% | 91 |
|
|
2015
Q1 | $842K | Hold |
8,579
| – | – | 0.13% | 88 |
|
|
2014
Q4 | $809K | Sell |
8,579
-3,604
| -30% | -$373K | 0.13% | 88 |
|
|
2014
Q3 | $1.3M | Buy |
12,183
+264
| +2% | +$25.9K | 0.2% | 79 |
|
|
2014
Q2 | $988K | Hold |
11,919
| – | – | 0.15% | 94 |
|
|
2014
Q1 | $845K | Sell |
11,919
-520
| -4% | -$40.8K | 0.13% | 96 |
|
|
2013
Q4 | $934K | Buy |
12,439
+797
| +7% | +$55.5K | 0.15% | 92 |
|
|
2013
Q3 | $732K | Hold |
11,642
| – | – | 0.13% | 100 |
|
|
2013
Q2 | $597K | Buy |
+11,642
| New | +$607K | 0.11% | 107 |
|
Other funds holding GILD
VCM
VPM
Grandfield & Dodd's GILD Position: Q1 2026 in Review
Grandfield & Dodd reduced its Gilead Sciences (GILD) stake by 4.9% in Q1 2026, selling an estimated $1.18M and leaving 163,600 shares worth $22.8M. The position accounts for 1.29% of the portfolio, ranked #29.
Grandfield & Dodd first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $31.6M in Q1 2025. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Grandfield & Dodd held 163,600 shares of Gilead Sciences worth $22.8M as of Q1 2026.
- Grandfield & Dodd sold 8,425 Gilead Sciences shares in Q1 2026, an estimated $1.18M.
- Gilead Sciences made up 1.29% of Grandfield & Dodd's portfolio in Q1 2026, its #29 holding.
- Grandfield & Dodd first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Grandfield & Dodd's Gilead Sciences position peaked at $31.6M in Q1 2025.
- 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Grandfield & Dodd's 13F filing for Q1 2026, filed 7 May 2026.